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Abstract
Whilst the role of ATF6α in modulating the unfolded protein response (UPR) has been well documented, the
function of its paralogue ATF6β is less well understood. Using knockdown in cell culture and gene ablation in
mice we have directly compared the roles of ATF6α & β in responding to the increased ER stress induced by
mutant forms of type X collagen that cause the ER stress-associated metaphyseal chondrodysplasia type
Schmid (MCDS). ATF6α more efficiently deals with the disease-associated ER stress in the absence of
ATF6β and conversely, ATF6β is less effective in the absence of ATF6α. Furthermore, disease severity in vivo
is increased by ATF6α ablation and decreased by ATF6β ablation. In addition, novel functions for each
paralogue are described including an ATF6β-specific role in controlling growth plate chondrocyte proliferation.
The clear demonstration of the intimate relationship of the two ATF6 isoforms and how ATF6β can moderate
the activity of ATF6α and vice versa is of great significance for understanding the UPR mechanism. The
activities of both ATF6 isoforms and their separate roles need consideration when deciding how to target
increased ER stress as a means of treating MCDS and other ER stress-associated diseases.
© 2018 University of Manchester. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
The normal homeostasis of the endoplasmic reticu-
lum (ER) depends on maintaining a balance between
the entry of the newly synthesised proteins into the ER,
their folding, the transit of correctly foldedproteins to the
Golgi, and the degradation of misfolded/unfolded
proteins. There are a number of different insults,
including expression of a mutant protein, which can
compromise this balance and cause ER-stress. The
elevatedER-stress is characterised by accumulation of
misfolded/unfolded proteins within the ER lumen.
Eukaryotic cells cope with ER stress by activating a
cascade of intracellular signalling pathways collectively
known as the unfolded protein response (UPR). The
classical UPR is mediated through three ER resident
transmembrane proteins; IRE1, PERK, and ATF6.
These UPR transducers are bound to the chaperone
BiP in their inactive state but as ER- stress increases,
BiP is sequestered into the ER lumen by interaction
with accumulating unfolded proteins. Loss of BiP
binding leads to activation of the stress sensors which
attempt to alleviate ER stress and restore ER
homeostasis in terms of protein folding. Activation of
the stress sensors i) enhances the ER-folding capacity
by up- regulation of chaperones such asBiP/GRP78; ii)
reduces the nascent protein load in the ER lumen by
PERK-dependent attenuation of general protein syn-
thesis; and iii) stimulates ER- associated degradation
(ERAD) by which misfolded proteins are retrotraslo-
cated to the cytoplasm, ubiquitinated and then degrad-
ed by the proteasome [1–4].
Whilst the UPR is primarily an adaptive mecha-
nism to accommodate fluctuations in ER stress
caused by physiological/environmental changes in
demand for protein folding in the ER, its prolonged
activation has been linked to the pathology of many
diseases including metaphyseal chondrodysplasia
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type Schmid (MCDS), a mild dwarfism caused by
mutations in the gene encoding type X collagen [5].
The UPR response in MCDS allows survival of
chondrocytes, but it alters the differentiation of
hypertrophic chondrocytes and ultimately impairs
bone growth and results in an expanded cartilage
growth plate hypertrophic zone (HZ) [6–8]. Tran-
scriptome analysis of the growth plate HZ in a knock-
in mouse model of MCDS carrying the Col10a1 p.
N617K MCDS-causing mutation revealed increased
ER stress and a robust UPR characterised by
activation of all three canonical ER stress sensors,
Atf6, Perk, and Ire1 in response to the intracellular
retention of mutated and misfolded collagen X protein
within the hypertrophic chondrocytes [6–8]. The role of
Ire1/Xbp1 signalling pathway in MCDS pathology was
shown to be of little biological importance, as
chondrocyte-specific ablation of Xbp1 in MCDS mice
(Col10a1 p.N617K) did not alter the disease severity
in MCDS [9]. The role of Atf6 and Perk signalling
pathways in the MCDS diseasemechanism remained
to be identified. Here we used in vitro and in vivo
approaches to investigate the role of the Atf6 branch of
the UPR in the MCDS diseasemechanism. ATF6 has
two isoforms, ATF6α and ATF6β. Both isoforms are
ubiquitously expressed ER-localised basic leucine
zipper (bZIP) transcription factors consisting of an
N-terminal cytoplasmic domain with transcriptional
activity, a transmembrane segment, and an ER
luminal domain that senses ER-stress [10–12].
In addition to structural similarities, ATF6α and
ATF6β also share the same mechanism of activation
under ER stress, which is translocation from ER to
the Golgi apparatus where they are sequentially
cleaved at their luminal and transmembrane do-
mains with Golgi- resident proteases S1P and S2P,
resulting in liberation from the ER membrane of
their cytosolic N-terminal regions, designated as
ATF6α(N) and ATF6β(N) [10,11,13]. These cleaved
and activated forms subsequently migrate to the
nucleus where they bind as homo- or heterodimers
to the promoter of genes containing ER stress
response elements (ERSE-I and -II), originally
identified in the genes encoding the ER chaperones
such as BiP, and induce transcription [10,11,14–17].
Previous work has established that there is a
functional redundancy between two isoforms of
ATF6 as a single knockout of each ATF6 isoform
in mice or fish was without phenotypic effect in the
absence of exogenous ER stress whereas their
double deficiency was embryonically lethal [18–20].
Despite the presence of an overlapping and com-
pensatory function between isoforms of Atf6, there is
some evidence for isoforms having distinct functions
which are not redundant and only become apparent
under conditions of increased ER stress. For instance,
Atf6α komice develop liver steatosis when challenged
with tunicamycin whereas Atf6β ko mice do not
[21,22]. Also, ATF6β, but not ATF6α, has been
shown to have a specific role in the regulation of the
PIGF andWfs1 genes [23,24]. Studies on each isoform
have indicated that ATF6α is inducible by increases in
ER stress whereas ATF6β is not [18,25–27]. In
addition, ATF6α appears to have a higher transcrip-
tional activity than ATF6β [25,26].
Given that ATF6β, like ATF6α, senses and
becomes activated in response to the accumulation
of unfolded/misfolded proteins within the ER, it would
be logical to expect activation of ATF6β in MCDS.
However, only induction and activation of ATF6α has
been studied to date [6,7]. Here we make the first
direct and systematic comparison of the roles of
ATF6α and -β under ER stress caused by the
expression of a variety of MCDS-causing collagen X
mutations in our cell culture model of the disease
activated UPR [28]. In addition, we crossed Atf6α
and Atf6β knockout mice with Col10a1 p.N617K
mouse model of MCDS to investigate the role of
each isoform in the MCDS disease mechanism in
vivo. We demonstrate that Atf6β, like Atf6α, is
involved in the MCDS disease mechanism. The
two isoforms of Atf6 play some distinct roles in
modulating the MCDS-mediated ER stress but, also
work in concert to finely tune the extent and
magnitude of Atf6-mediated UPR response. Our
results also reveal a beneficial role for Atf6α but a
detrimental role for Atf6β, in modulating the disease
severity in MCDS and an indispensable role for Atf6β
in controlling chondrocyte proliferation in the murine
growth plate.
Results
Loss of ATF6α but not ATF6β compromises the
cells ability to respond to increased ER stress
induced by the expression of mutant collagen X
MCDS pathology arises as a direct result of ER
stress caused by intracellular retention of mutated and
misfolded collagen X protein [7,8]. To determine the
role of ATF6 in this process, we first used an in vitro
approach toexamine the consequences ofATF6α and
β knockdown on the level of ER stress induced in our
MCDS cell culture models (HeLa cells transiently
expressing one of four different MCDS-causing
mutant forms of collagen X protein). Consistent with
previous studies [6,7], ATF6α mRNA was induced in
cultures expressing each of the MCDS mutant forms
of collagen X tested (S1a Fig.). In addition, ATF6β
mRNA was also mildly induced by the expression of
each of the MCDS constructs compared to un-
transfected (UTF) cells (S1b Fig.). The expression of
both ATF6α and ATF6β mRNAs were efficiently and
selectively knocked down/silenced in all four MCDS
mutant-expressing cell cultures co-transfected with
the respective siRNAs (S1a–bFig.). These changes in
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ATF6α & β mRNAs were also apparent at the protein
level (S1c–f Fig.) confirming the relative efficiency of
the knockdown protocol (see Materials and methods).
We next tested the ability of these MCDS mutant-
expressing cells to induce ER stress- associated
genes that are, at least in part, ATF6-dependant in the
absence (or marked reduction) of each isoform of
ATF6. The results for the Col10a1p.N617 K construct
are presented in Fig. 1 and discussed below; results
for the other 3 constructs (NC1del10, p.Y598D &
p.G618V) are presented in S2 & S3 Figs. The
expression of p.N617K induced BiP and CHOP
mRNA (Fig. 1a & b) and also induced the chaperones
ARMET andCRELD2 (Fig. 1c & d). The knockdown of
ATF6α prevented the induction ofBiP,CHOPARMET
and CRELD2 mRNAs in cells expressing p.N617K
whereas the knockdownofATF6β had little to no effect
on the expression of thesemRNAs (Fig. 1a–d). Similar
results for the effects of ATF6α & β with one or two
minor differences were obtained when expressing the
3 otherMCDS-causing collagenXmutations (S2 Fig.).
These results demonstrate that, as expected based
on previous work, ATF6α (but not ATF6β) plays a key
role controllingBiPandCHOP induction in response to
the ER stress induced by the expression of mutant
collagen X. ATF6α also plays a role in the induction of
ARMETmRNAwhereas a role for ATF6β is less clear
cut. CRELD2 induction appeared to be ATF6α
dependent only in the context of the ER stress induced
by the p.N617K mutation (Fig. 1d and S2 Fig. d).
Knockdown of ATF6β suppresses MCDS-induced
IRE1 pathway activity whereas knockdown of
ATF6α stimulates the PERK pathway
Although BiP and CHOP mRNAs are often used
as crude indicators of the level of ER stress in a
system, this association is lost when you interfere
Fig. 1. Effects of ATF6α and ATF6β knockdown in cells expressing p.N617K MCDS-causing mutant form of collagen X
protein. The expression of either ATF6α or ATF6β was knocked-down in HeLa cells using siRNAs. These cells were then
transiently transfected with expression constructs encoding either the wild type collagen X or p.N617K mutant form of the
protein. 48 h post transfection, (a) RNA was extracted and analysed with real time qPCR for the expression of (a) BIP,
(b) CHOP, (c) ARMET and (d) CRELD2 and (e) the spliced XBP1, XBP1s. Mean ± SEM (n = 5). *p b 0.05, **p b 0.01, ***p b
0.001, ****p b 0.0001. Untransfected cells (UTF) served as controls. (f) Cell lysates were extracted and immunoblotted using an
anti- ATF4 antibody. The level of ATF4 protein was quantified relative toGAPDH loading control. Values represent Mean ± SEM
from three independent experiments. ***p b 0.001, ****p b 0.0001 as determined by ANOVA. UTF: Untransfected cells. Typical
western blots for ATF4 and collagen X proteins in ATF6α or ATF6β siRNA-mediated knocked down cells expressing N671K.
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with the expression of major regulators of their
expression such as ATF6 as described above. In
order to gain insight into the effects of ATF6
knockdown on the overall levels of ER stress
experienced by cells expressing the mutant forms of
collagen X, the activities of the IRE1 and PERK
pathways were assessed by measuring the levels of
spliced XBP1 (sXBP1) mRNA (Fig. 1e and S3a Fig.)
and ATF4 protein (Fig. 1f & g and S3b–f Fig.)
respectively.
The expression of p.N617K induced increased
levels of sXBP1 mRNA indicating increased IRE1
activity. ATF6α knockdown further increased the level
of sXBP1 in the p.N617K expressing cells (Fig. 1e) but
either decreased slightly, or had noeffect on, the levels
of sXBP1 in cells expressing the other mutant forms of
collagen X (S3a Fig.). It is noteworthy that in all cases,
knockdown of ATF6β prevented the increase in
sXBP1 induced by the expression of the mutant
forms of collagen X (Fig. 1e; S3a Fig.).
Increased levels of ATF4 protein are indicative of
increased PERK signalling [29]. The expression of
the p.N617K MCDS-causing collagen X construct
resulted in a significant increase in ATF4 protein
compared to the un-transfected controls (Fig. 1f & g).
ATF6α knockdown further increased the levels of
ATF4 whereas ATF6β knockdown had no effect
(Fig. 1f & g). Representative western blots of ATF4
protein in cells expressing the different forms of
mutant collagen are shown (Fig. 1g & S3 c–f Fig.)
along with the levels of intracellular collagen X
accumulation in the same cell extracts. There was a
clear reciprocal relationship between the levels
of collagen X and the levels of ATF4 in each
transfected cell extract. When ATF4 was high,
indicating increased PERK signalling and a de-
crease in general protein synthesis due to increased
eIF2α phosphorylation, the level of intracellular
collagen X was reduced and vice versa (Fig. 1g &
S3c–f Fig.).
These latter results suggest that the loss of ATF6α
causes an increase in ER stress level indicated by
increased PERK signalling which accounts for both
the increased ATF4 protein and the reduced
synthesis of the mutant collagen X. The reduced
level of collagen X accumulation following ATF6α
knockdown was not caused by decreased COL10A1
mRNA levels as these were unaffected by the
knockdown of either isoform (S1g Fig.) and are
unlikely to have been caused by increased secretion
since the mutant proteins are largely retained in the
ER in cell culture models [30]. The fact that that
ATF6β knockdown prevented the MCDS-induced
increase in sXBP1 suggests that the UPR is more
effective in the absence of ATF6β, possibly due to its
previously reported capacity to attenuate the activity
of ATF6α [25,26].
Hence, the sXBP1 and ATF4 results suggest that
ATF6α operates in a more efficient manner in terms
of managing increased levels of ER stress in the
absence of ATF6β. On the basis of the cell culture
experiments described above, we hypothesized
that ablation of Atf6α in the mouse MCDS model
(Col10a1p.N617K) would cause a more severe-, and
ablation of Atf6β a milder-, phenotype respectively.
We therefore crossed the MCDS and Atf6α− /− or
Atf6β− /− lines and phenotyped the resulting mice.
ATF6α ablation increases disease severity in the
ER stress-related dwarfism MCDS
In the first instance, we made a detailed study of
the growth and growth plate histology of the Atf6α− /−
mouse to ensure there were no subtle skeletal
phenotypes that could have been missed on initial
investigation [18,19]. The growth plates of Atf6α− /−
Table 1. Effects of Atf6α ablation on the skeletal development and body weights of MCDS mice over a 9 week period.
Body measurements Genotypes 3 weeks 6 weeks 9 weeks
Male Weight (g) Atf6α+/+/MCDS 9.7 ± 0.3 (15) 19.3 ± 0.5 (13) 22.3 ± 0.1 (5)
Atf6α−/−/MCDS 9.0 ± 0.5 (8) 18.8 ± 0.6 (11) 22.6 ± 0.8 (5)
Femur length (mm) Atf6α+/+/MCDS 8.8 ± 0.1 (8) 10.8 ± 0.1 (9) 11.8 ± 0.1 (6)
Atf6α−/−/MCDS 8.4 ± 0.1 (6)* 9.9 ± 0.2 (9)*** 11.1 ± 0.2 (5)**
Tibia Length (mm) Atf6α+/+/MCDS 10.4 ± 0.1 (8) 12.0 ± 0.1 (9) 12.5 ± 0.1 (6)
Atf6α−/−/MCDS 9.7 ± 0.1 (6)*** 11.1 ± 0.3 (9)*** 12.0 ± 0.1 (5)
ICD (mm) Atf6α+/+/MCDS 5.0 ± 0.01 (8) 5.1 ± 0.01 (9) 5.2 ± 0.1 (6)
Atf6α−/−/MCDS 5.0 ± 0.04 (6) 5.1 ± 0.01 (9) 5.1 ± 0.2 (5)
Female Weight (g) Atf6α+/+/MCDS 9.0 ± 0.2 (18) 16.2 ± 0.3 (13) 17.3 ± 0.2 (8)
Atf6α−/−/MCDS 8.2 ± 0.3 (24) 15.4 ± 0.6 (7) 17.6 ± 0.3 (5)
Femur length (mm) Atf6α+/+/MCDS 8.6 ± 0.1 (15) 10.4 ± 0.1 (13) 11.2 ± 0.1 (9)
Atf6α−/−/MCDS 8.1 ± 0.1 (8)** 9.3 ± 0.1 (7)*** 10.8 ± 0.2 (5)**
Tibia Length (mm) Atf6α+/+/MCDS 10.1 ± 0.1 (15) 11.6 ± 0.2 (13) 12.3 ± 0.1 (9)
Atf6α−/−/MCDS 9.4 ± 0.2 (8)**** 9.9 ± 0.2 (7)*** 11.5 ± 0.3 (5)****
ICD (mm) Atf6α+/+/MCDS 5.0 ± 0.03 (15) 5.1 ± 0.01 (13) 5.2 ± 0.1 (9)
Atf6α−/−/MCDS 5.0 ± 0.01 (8) 5.1 ± 0.01 (7) 5.2 ± 0.1 (5)
Mean ± SEM (n): *p b 0.05, **p b 0.01, ***p b 0.001, and ****p b 0.0001 when compared to Atf6α+/+/MCDS. All statistical analysis by
ANOVA. (ICD = Inner canthal distance).
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mice were indistinguishable from the wild type
equivalents based on appearance and histomorpho-
metry (S4a & b Fig.). The body weights and bone
lengths of wild type and knockout mice at 3 weeks of
age were also indistinguishable (S4c & d Fig.).
The body weights of the MCDSmice (homozygous
for the Col10a1p.N617K mutation) with ablated
Atf6α (hereafter referred to as Atf6α− /−/MCDS)
were slightly, albeit mostly not significantly, lower
than their Atf6α+/+ counterparts (Atf6α+/+/MCDS) at
Fig. 2. Effects of Atf6α ablation on the growth plate pathology associated with MCDS. (a) H & E staining of tibial growth
plat. (b) Widths of hypertrophic zones at three weeks of age. Mean ± SEM (N) (**p b 0.01 compared to Atf6α+/+/MCDS,
****p b 0.001 compared to Atf6α+/+). Immunohistochemistry for (c) collagen X, (d) Bip, and (e) Creld2 in three week old
mice with specified genotypes. The vertical black lines delineate the hypertrophic zones. (f) Images represent
immunohistochemistry for BrdU performed on tibial growth plate sections of three week old MCDS mice that were either
wild type of knockout for Atf6α. (g) Percentage of BrdU labelled nuclei (black stained) calculated against the total number of
cells in the proliferative zone. Mean ± SEM (n = 5). (h) A representative western blots of rib growth plate extracts at three
weeks of age for Bip and Creld2. Coomassie blue stained gel was used as loading control. (i & j) Quantification of Bip and
Creld2 from three independent analysis. All statistical analysis by ANOVA (**p b 0.01, ***p b 0.001 and ****p b 0.0001
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3 and 6 weeks of age (Table 1). Skeletal analysis at
3 and 6 weeks of age revealed significant reductions
in the endochondral bone lengths of both male and
female Atf6α− /−/MCDS mice (Table 1). These
differences were still apparent at 9 weeks of age
but had dropped below statistical significance in the
male tibias (Table 1). The inner canthal distance
(ICD) is determined by intramembranous bone
growth and was not altered by either MCDS [7] or
by Atf6α ablation (Table 1) demonstrating that the
reduced bone lengths in endochondral bones (e.g.
tibia and femur) are related to a growth plate defect
and do not result from a more generalized effect on
bone growth.
Atf6α ablation increases MCDS-associated
expansion of the growth plate hypertrophic
zone (HZ)
As has been noted previously, the growth plate
HZs of Atf6α+/+/MCDS mice were approx. 2.5-fold
wider than their non-MCDS wild type equivalents at
3 weeks of age. Nevertheless, the ablation of Atf6α
resulted in a further 14% expansion of the HZ of
MCDSmice (Fig. 2a & b; p b 0.01) which is indicative
of more severe ER stress in the Atf6α− /−/MCDS
mouse since the degree of HZ expansion in MCDS
directly and positively correlates with the disease
severity [7,8,28].
Although the HZ zone is wider in the Atf6α− /−
compared to Atf6α+/+/MCDS mouse, the pattern
of collagen X retention was comparable (Fig. 2c). In
contrast, the immunohistochemical staining for Bip in
the MCDS HZ was more intense in the Atf6α+/+
compared to Atf6α− / − growth plate (Fig. 2d).
Quantitation of Bip in rib growth plate extracts by
western blotting did not reveal a significant difference
in the levels between the Aft6 sufficient and deficient
MCDS mice (Fig. 2h & i), whereas mRNA levels,
assessed by qPCR were higher in the Atf6α+/+
MCDS mice (S6a Fig.). The upregulation of HZ
Creld2 apparent by immunolocalisation in MCDS
mice was markedly suppressed by Atf6α ablation
(Fig. 2e) and similar results were obtained by western
blotting (Fig. 2h & j) and qPCR (S6b Fig.) of rib
growth plate extracts. BrdU labelling revealed no
differences in growth plate chondrocyte proliferation
between Atf6α+/+/MCDS and Atf6α− /−/MCDS mice
(Fig. 2f & g).
Atf6α ablation decreases growth plate
histomorphometric markers of bone growth
in MCDS mice
Whereas the expression of Col10a1 mRNA was
apparent as a neat band in all hypertrophic chondro-
cytes apart from the most terminal in the non-MCDS
wild type controls (Atf6α+/+ & Atf6α− /−), the pattern of
expression was disrupted and more sporadic in
MCDS. Atf6α ablation had little influence in the
MCDS mouse pattern in comparison with the Atf6α+/
+/MCDS control (Fig. 3a). Bip mRNA was clearly
highly upregulated in the expanded growth plate of the
Atf6α+/+/MCDS mouse whereas the induction of Bip
was noticeably less intense in the Atf6α− /−/MCDS
growth plate HZ (Fig. 3b; see also S6a Fig.).
Osteopontin (Opn) mRNA expression is normally
limited to the most terminally differentiated hypertro-
phic chondrocytes adjacent to the vascular invasion
front (see Fig. 3c - Atf6α+/+ panel). Surprisingly,
Atf6α− /− (non-MCDS) mice expressed Opn mRNA in
hypertrophic chondrocytes throughout the HZ zone
(Fig. 3c). In MCDS mice expressing Atf6α, terminal
differentiation becomes cell autonomous and Opn
becomes expressed sporadically by hypertrophic
chondrocytes in the lower half of the HZ as cells
complete their differentiation (Fig. 3c) [7,8]. In MCDS
(unlike on a wild-type collagen X background), Atf6α-
− /− did not affectOpn expression in comparison to the
Atf6α+/+/MCDS control (Fig. 3c). Similarly to Opn,
Mmp13mRNAwas also restricted to themost terminal
hypertrophic chondrocytes in wild type mice but was
expressed sporadically by individual hypertrophic
chondrocytes in the HZ of Atf6α+/+/MCDS mice
(Fig. 3d) [7,8]. Again Atf6α ablation did not affect
the expression of Mmp13 in Atf6α− /−/MCDS mice
(Fig. 3d).
The expansion of growth plate width in MCDS is
due to decreased osteoclast recruitment to the
vascular invasion front resulting in a decreased
rate of hypertrophic cartilage erosion [7]. We
therefore quantified the effects of Atf6α ablation on
osteoclast recruitment to the vascular invasion front
by staining the osteoclasts with tartrate resistant
alkaline phosphatase (TRAP). Atf6α ablation in mice
wild type for Col10a1 had no effect on osteoclast
numbers at the vascular invasion front (Fig. 3e & h).
As described previously, MCDS (Atf6α+/+/MCDS)
reduced osteoclast recruitment approx. 30% and
notably, Atf6α ablation caused a further significant
20% fall in TRAP-stained cells at the vascular invasion
front in Atf6α− /−/MCDS mice (Fig. 3e & h). This
reduction in osteoclasts accounts for the further
expansion in HZwidth seen in theMCDSmice lacking
Atf6α. Longitudinal bone growth is in large part
determined by the size or “height” that the hypertrophic
chondrocytes achieve during terminal differentiation
[31]. The heights achieved by the hypertrophic
chondrocytes in the Atf6α− /−/MCDS mice were
significantly less than equivalent cell heights achieved
in the Atf6α+/+/MCDS HZ (Fig. 3f & h) accounting for
the reduced bone lengths seen in theMCDSmice that
lacked Atf6 (Table 1). In wild type mice, apoptosis is
usually restricted to the terminal hypertrophic chon-
drocytes in the vicinity of the vascular invasion front
(Atf6α+/+ − Fig. 3g). Atf6α ablation on a wild type
collagen X background did not alter this distribution
(Atf6α− /− − Fig. 3g). As previously noted in a recent
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Fig. 3. (legend on next page)
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study [9]MCDScaused an increase in Tunnel-positive
apoptotic cells distributed through the lower half of the
HZ (Atf6α+/+/MCDS - Fig. 3g & h). Atf6α ablation
significantly reduced the numbers of apoptotic chon-
drocytes distributed throughout the lower half of theHZ
(Atf6α− /−/MCDS – Fig. 3g & h) presumably due
reduced expression of Atf6α-dependent Chop (see
Fig. 1b in vitro and S6c Fig. in vivo). The reduction in
Chop, which correlates with apoptosis rates in vivo is
intriguing given that both in vitro (Fig. 1f) and in vivo
(Fig. 4b & d) ATF4 levels were increased in MCDS
cells/tissues lacking ATF6α. These data strongly
suggest that the induction ofCHOP ismoredependent
upon ATF6α than ATF4.
Atf6α ablation in MCDS mice increases growth
plate ER stress based on measures of signalling
through the Ire1 and Perk pathways
The levels of Xbp1 mRNA splicing (Xpb1s) were
assessed in rib growth plate extracts as a measure of
signalling through the Ire1 pathway. MCDS caused an
increase in the proportion ofXpb1s present in samples
(Atf6α+/+/MCDS) and the levels of splicingwere further
increased in the Atf6α− /−/MCDS mice (Fig. 4a & c).
Signalling through the Perk pathway was assessed by
measuring the levels of Atf4 protein in rib extracts by
western blotting. Similar to the Xpb1s, MCDS caused
an increase in the level of Atf4 protein (Atf6α+/+/MCDS
– Fig. 4b & d) with Atf6α ablation inducing a further
significant increase (Atf6α− /−/MCDS mice - Fig. 4b &
d). Therefore, Atf6α ablation resulted in increased
signalling through both the Ire1 and Perk pathways in
MCDS mice.
In summary,Atf6α ablation resulted in amore severe
phenotype inMCDSmice based on decreased rates of
bone growth (Table 1), histopathology, histomorpho-
metry and histochemistry (Fig. 2), decreased markers
of hypertrophic chondrocyte differentiation (Fig. 3) and
biochemical evidence for increased signalling flux
through the Perk and Ire1 pathways (Fig. 4). Paradox-
ically, the Atf6α− /−/MCDS mice exhibited a reduced
level of apoptosis in the HZ compared to the Atf6-
sufficient MCDS mice suggesting that hypertrophic
chondrocyte apoptosis per se has no direct influence
on the disease severity in this disease. We next
tested the second part of our hypothesis, namely that
Atf6β ablation would decrease the disease severity in
MCDS.
Effects of Atf6β ablation on normal mouse
skeletal growth
To ensure there were no subtle skeletal phenotypes
caused by Atf6β ablation that may have been missed
during the initial phenotyping, we measured body
weights, and long bone lengths from x-rays of 3 week
old mice. Surprisingly, we found that for Atf6β
knockouts, both male and female mice were slightly,
but significantly lighter and their tibias and femurswere
also slightly shorter than their wild type controls
(Fig. 5). The inner canthal distances of the knockouts
and controls however were identical showing that the
skeletal effects of Atf6β ablation were on endochon-
dral but not intramembranous bone formation. We
next conductedagrowth plateexamination ofwild type
(Atf6β+/+) and knockout (Atf6β− /−) mice. The histo-
logical appearance, histomorphometry of the different
zones, immunolocalisation of collagen X, Bip and
Creld2 and gene expression of Col10a1, Bip, Creld2,
Opn and Mmp13, were indistinguishable between the
wild type andAtf6β− /−mice (Fig. 6a–h and l). However,
BrdU labeling revealed a significant decrease in the
proliferation rate of growth plate chondrocytes in the
Atf6β− /− mice (Fig. 6i & l) whereas the height of
the terminal hypertrophic chondrocytes (Fig. 6j & l) and
the numbers of TRAP-positive osteoclasts recruited to
the vascular invasion front (Fig. 6k & l) did not
significantly differ between the genotypes. According-
ly, we concluded that the reduced bone growth in the
Atf6β knockout mouse was caused by a proliferative
zone defect.
Clearly, this would confound interpretation of
growth and skeletal measurements of Atf6β− /−/
MCDS mice since any differences from the Atf6β+/
+/MCDS would be the compound result of both a
proliferative and a hypertrophic zone defect. Never-
theless, direct comparisons of the severity of the
growth plate hypertrophic zone phenotypes of the 2
MCDS lines would still provide insights into some
Fig. 3. Effects of Atf6α ablation on chondrocytes differentiation. Tibial growth plates from three week old mice with
specified genotypes were analysed for the expression of mRNAs encoding (a) Col10a1, (b) Bip, (C) Osteopontin, and
(d) Mmp13. The presence of transcript is indicated by the dark blue staining. The hypertrophic zone is indicated by the
vertical red line and the vascular invasion front by the yellow dashes. (e) TRAP staining for osteoclasts (arrows) at the
vascular invasion front (arrow head). The number of osteoclast per mm of vif is represented in the table h. (f) Snapshot of
measurement of height of the most terminal hypertrophy chondrocytes (HCs) for each specific genotype. HCs are
indicated by the red vertical lines and their corresponding measurements are highlighted in green. (arrow head = vif).
Table (h) represents the average heights of the most terminal HCs. (g) TUNEL assay on tibial growth plate sections of
three week old animals with specific genotypes. (Green stained cells = apoptotic cells, blue-stained cells = DAPI,
red dotted lines = vascular invasion front). Table (h) shows the number of apoptotic HCs as a percentage of the total
number of chondrocytes within HZ. (h) Mean ± SEM (N) (*p b 0.05 and **p b 0.01 compared to Atf6α+/+/MCDS, #p b 0.01
and # #p b 0.001 compared to ATF6α+/+). All statistical analysis by ANOVA.
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aspects of the ER stress being experienced in the
presence and absence of Atf6β.
Atf6β− /−/MCDS and Atf6β+/+/MCDS mouse body
weight and bone growth data
Atf6β− /−/MCDS mice were lighter and had shorter
long bones than their Atf6β+/+/MCDS controls. As
discussed above, since the Atf6β− /−/MCDS mice
have a proliferative zone defect that was not present
in the Atf6β+/+/MCDS mice, interpretation of the data
is confounded. Therefore, the data set is presented
in S5 Fig. for the sake of completeness but is not
discussed further here.
Ablation of Atf6β decreased the severity of the
growth plate HZ pathology in MCDS mice
Histological examination revealed that the MCDS-
induced expansion in the width of the HZ was
Fig. 4. Effects ofAtf6αablation on the activities of PERKand IRE1 signalling pathways. (a) Total RNA from three pooled ribs
growth plate extracts of 21-day old mice were extracted and subjected to qPCR with XBP1 primers. Gel shows three
independent samples for each genotype. Upper bands on the gel indicates Xbp1(U) with the size of 205 bp and lower band is
Xbp1s (size = 179 bp). (b) A typical western blots of rib growth plate extracts at three weeks of age for Atf4. Coomassie blue
stained gel was used as loading control. (C) The average rate of Xbp1 splicing from five independent samples for each
genotype. (d) Quantification of Atf4 from five independent analyses (*p b 0.05, **p b 0.01, ***p b 0.001, ****p b 0.0001).
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Fig. 5. Effects of Atf6β ablation on the skeletal development and body weight of three week old mice. (a) A
representative X-ray radiograph image for three-week old male mice (top row) and female mice (bottom row) with the
specified genotypes. White scale bar = 100 μm (b) Mean ± SEM (N). *p b 0.05 and ***p b 0.001 when compared to Atf6β+/
+mice. All statistical analysis by ANOVA.
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Fig. 6. Analysis of growth plate in three week old Atf6β−/− mice. (a) H & E staining of tibial growth plate and
immunohistochemistry for (b) collagen X, (c) Bip, and (d) Creld2. The vertical black lines delineate the hypertrophic zones.
Grey dashed lines indicated vascular invasion front. In situ hybridisation for (e) Col10a1, (f) Bip (g) osteopontin, and
(h)Mmp13mRNAs. The presence of transcript is indicated by the dark blue staining. HZ is shown by the vertical red lines.
(i) 5-bromo-29-deoxyuridine (BrdU) labelling of proliferative cells in the growth plate. Positive cells stained black.
(j) Snapshots of height measurement in the most terminal hypertrophic chondrocytes (HCs). Hypertrophic chondrocytes are
indicated by red vertical lines and their corresponding measurements are highlighted in green. Scale bar = 50 μm. (k) TRAP
staining for osteoclasts (arrows). Closed arrow head = vascular invasion front. (l) Mean ± SEM (N = 5). **p b 0.01 as
determined by ANOVA.
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significantly reduced in the Atf6β− /−/MCDS mice
compared to their Atf6β+/+/MCDS controls (Fig. 7a &
b). The intracellular retention of mutant collagen X in
Atf6β− /−/MCDS mice was limited to the upper part of
the HZ but extended much further in the Atf6β+/+/
MCDS growth plate. The apparent increased intensity
of immune-stain in the mice lacking Atf6βmay indicate
more efficient secretion of the mutant collagen X into
the ECM (Fig. 7c). Immunostaining for Bip was
restricted and limited to the upper region of the HZ in
Atf6β− /−/MCDSmice (Fig. 7d)whereasCreld2 staining
was similar in Atf6β+/+/MCDS and Atf6β− /−/MCDS
mice extending throughout the HZ (Fig. 7e). Western
blotting and qPCR of rib growth plate extracts revealed
that both Bip and Creld2 were significantly increased in
theMCDSmice but the level of Bip andCreld2were not
significantly altered by Atf6β ablation in MCDS mice
(Fig. 7f–h; S6d & e Fig.).
Atf6β ablation amelioratedHZmarkers of deficient
differentiation and reduced bone growth in MCDS
mice
Col10a1 mRNA expression was more intense and
continuous throughout the HZ of the Atf6β− /−/MCDS
mice compared to the Atf6β+/+/MCDS controls that
displayed the typical interrupted expression pattern
usually associated with MCDS (Fig. 8a). Bip
expression was focused to the prehypertrophic and
very first hypertrophic chondrocytes and then down-
regulated in the remainder of the HZ apart from a few
sporadic cells in animals lacking Atf6β (Atf6β− /−/
MCDS - Fig. 8b). In contrast, the sporadic expres-
sion of Bip mRNA was far stronger in the HZ of the
control MCDS mice (Atf6β+/+/MCDS – Fig. 8b).
The expression of Opn mRNA was more focused
to the terminal hypertrophic chondrocytes adjacent
to the vascular invasion front in MCDS lacking
Atf6β− /− (Fig. 8c) whereas Mmp13 expression was
similar in the Atf6β+/+/MCDS and Atf6β− /−/MCDS
mice (Fig. 8d). Where the Atf6β− /−/MCDS differ from
their Atf6β-sufficient equivalents, the changes in
expression together with the reduced width of the HZ
are indicative of improved hypertrophic chondrocyte
differentiation more reminiscent of that seen in wild
type (non MCDS) mice. In addition, quantitation of
osteoclast recruitment to the vascular invasion front by
TRAP staining (Fig. 8e and g) and measurement of
hypertrophic cell “height” (Fig. 8f & h) also revealed
that Atf6β ablation at least partially ameliorated the
MCDS-induced decreases in these histological indi-
cators of bone growth, again indicative of improved
hypertrophic chondrocyte differentiation.
Atf6β ablation in wild type (non MCDS) mice did
not affect apoptosis as judged by TUNEL staining
which was restricted to hypertrophic chondrocytes at
the vascular invasion front (Fig. 8i). The increased
apoptosis in the hypertrophic zone of MCDS mice
replete with both forms of Atf6 (Atf6β+/+/MCDS – Fig.
8i; Atf6α+/+/MCDS – Fig. 3g) was significantly
reduced in Atf6β− /−/MCDS mice (Fig. 8i and j).
This was accompanied by a significant fall in the
level of Chop mRNA in the Atf6β− /−/MCDS com-
pared to Atf6β+/+/MCDS mouse growth (S6f Fig.).
Atf6β ablation in MCDS mice decreases growth
plate ER stress based on measures of signalling
through the Ire1 and Perk pathways
As expected, signalling through the Ire1 pathway,
based on sXbp1 mRNA levels, was significantly
increased in the growth plate of control Atf6β+/+/
MCDS mice. The ablation of Atf6β significantly
reduced the MCDS-associated increased splicing of
Xbp1 (Fig. 9a & c). Similarly, signalling through the
Perk pathway, assessed by measuring the level of
Atf4 protein in growth plate extracts, was increased, as
expected, in the control Atf6β+/+/MCDS mice but in
comparison significantly decreased by Atf6β ablation
(Fig. 9b & d). The reduced levels of signalling through
both the Ire1 and Perk pathways and the reduced
Chop (S6f Fig.) strongly suggest that the levels of ER
stress are significantly reduced by Atf6β ablation and
that this reduced ER stress is the mechanism
responsible for the improved histological appearance
of the growth plate in the Atf6β− /−/MCDS mice.
These findings from in vivo studies therefore support
our original hypothesis that Atf6α ablation would be
detrimental in terms of MCDS disease severity and
that ablation of Atf6β would be beneficial.
Discussion
While both ATF6α and -β undergo proteolytic
cleavage and become activated following accumula-
tion of unfolded/misfolded protein within the ER (ER
stress), surprisingly only ATF6α has been implicated
in the pathology of many ER stress-associated
diseases and has been themain focus of most studies
[32–41]. Comparatively few studies have examined
the function of ATF6β [11,18,20,23–26,36,42] and
several of these have concluded that ATF6β either
does not have any physiological significance or has a
minor functional significance that is redundant with
that of ATF6α [36,42]. The functional significance of
ATF6β and its possible therapeutic potential has
therefore been largely ignored in many ER stress-
associated diseases, including MCDS.
Shared and novel roles for ATF6α and ATF6β
Our analyses provide a direct and systematic
comparison between ATF6α and -β in response to
ER stress caused by a pathophysiologically relevant
intracellular accumulation of misfolded mutant pro-
tein within the ER in the context of MCDS – a disease
which is driven by increased ER stress and the
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Fig. 7. (legend on next page)
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resulting UPR [7,8,28]. The results provide new
insight into the role of ATF6α and -β and interplay
between them since, particularly in the in vivo part of
the study, we could measure not only biochemical
parameters of ER stress but concurrently assess the
effects of Atf6 ablation on disease severity.
Firstly, it is clear from previous work that some of
the functions of ATF6α and -β are not only vital for
normal development but shared by both isoforms
(redundant) since each isoform alone can support
essentially normal development but ablation of both
isoforms is embryonic lethal in mouse and fish
[18–20]. Nevertheless, this does not preclude either or
both isoforms of ATF6 acquiring exclusive responsi-
bilities for ancestral roles (sub-functionalisation) or
acquiring completely new roles (neo-functionalisation)
although these latter roles cannot be essential since
development is normal in the absence of either
isoform.
Results presented in this study show that ATF6α is
both induced by increased ER stress (S1 Fig.) and
responsible for inducing the increased transcription
of a range of ER stress-associated factors such as
BiP, CHOP and ARMET whereas ATF6β is not
(Fig. 1 and S2 Fig.) as has been firmly established by
many others [11,18,19,25,26]. Another difference
between ATF6α & β relates to their ability to induce
CRELD2. The expression of the p.N617 K mutation
caused a marked ATF6α-dependent increase in
expression of CRELD2 in vitro (Fig. 1d) and in vivo
(Fig. 2) that was unaffected by the presence of
absence of ATF6β (Fig. 7). In addition, Atf6α
appears responsible for suppressing the expression
ofOpn in all but terminally differentiated hypertrophic
chondrocytes of wild type (but not MCDS) mice
(Fig. 3c) whereas Atf6β plays an important role in
controlling growth plate chondrocyte proliferation
(Fig. 6i and l) although this latter effect may be
dependent upon genetic background since the original
Atf6β knockout mice were reported to be phenotypi-
cally normal [18].
The data presented here together with the
evidence cited above in the introduction relating to
liver steatosis in tunicamycin-challenged Atfα ko, but
not Atf6β ko mice, and the exclusive role of Atf6β in
regulating various genes, provides compelling evi-
dence that each of the two ATF6 isoforms have
acquired a number of exclusive roles since their
divergence from a common ancestral ATF6. The
biological function/significance of some of these new
roles remain to be determined but they would appear
to be wide-ranging.
Competing roles of ATF6α and ATF6β in
controlling ER stress?
The ER stress-related activities of ATF6α and β
are intimately related but it is the ATF6α isoform that
is a major transcriptional activator of ERSE genes
and is a prerequisite for a robust UPR (Fig. 1 and S2
Fig.) and [11,18,20], while ATF6β appears to
regulate the basal expression level of ATF6α-target
genes. In addition, the transcriptional activity of
ATF6α has been reported to be much greater than
that of ATF6β [25–27]. In an attempt to gain insight
into the overall effect of ATF6α & β knockdown on
the level of ER stress experienced by cells express-
ing the different MCDS-causing mutant forms of
collagen X, we measured the actual level of XBP1s
mRNA (rather than the ratio of XBP1s: total XBP1 –
see Materials and methods) as an indicator of IRE1
activity and ATF4 protein as a measure of PERK
signalling. The knockdown of ATF6β completely
prevented the mutant collagen X-induced increase in
XBP1s indicating that ATF6α on its own effectively
prevented the activation of the IRE1 pathway, an
effect that could not be achieved in the presence of
ATF6β either alone or in combination with ATF6α
(Fig. 1e and S3a Fig.). In a similar and related
fashion, knockdown of ATF6α (but not ATF6β)
caused a marked increase in ATF4 protein and an
accompanying decrease in collagen X synthesis
(Figs. 1f & g, and S3b–f), indicators of increased
PERK signalling, again suggesting a more pro-
nounced role for ATF6α is controlling the level of
ER stress. These data also indicate that the activity
of ATF6α is dampened, rather than “anatagonised”
as has been suggested previously [18] by the
presence of ATF6β and the reason for this will be
discussed later. Nevertheless, this effect of ATF6β
Fig. 7. Effects of Atf6β ablation on the growth plate pathology associated with MCDS. (a) H & E staining of tibial growth
plate in three week old MCDS mice that were either wild type or knockout for Atf6β. (b) Widths of hypertrophic zones at
three weeks of age. Mean ± SEM (N) (**p b 0.01 as determined by ANOVA). Immunohistochemistry for (c) collagen X,
(d) Bip, and (e) Creld2. The vertical black lines delineate the hypertrophic zones The black boxed photomicrographs
represent an expanded view of the indicated areas within hypertrophic zones in the sections from specified genotypes. The
intracellular accumulation of collagen X (black arrows) is only apparent in the upper hypertrophic zone in Atf6β−/−/MCDS
sample. The yellow horizontal arrow in the expanded view of Atf6β−/−/MCDS sample indicates the transition region in
which; (c) intracellular accumulation of collagen X protein is resolved and collagen X protein is secreted (d) Bip is down-
regulated. (f) A representative western blots of rib growth plate extracts at three weeks of age for BiP and CRELD2.
Coomassie blue stained gel was used as loading control. (g & h) Quantification of Bip and Creld2 from three independent
analysis (***p b 0.001).
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on the activity of ATF6α led us to hypothesise that
the MCDS phenotype in mice would be made more
severe by Atf6α ablation and ameliorated by ablation
of Atf6β.
Atf6α ablation in MCDS mice increased the overall
levels of ER stress in the growth plate, as judged by
IRE1 (Xbp1 slicing) and PERK pathway (ATF4
protein) activities (Fig. 4) as was found in our earlier
in vitro experiments (Fig. 1e–g and S3 Fig.).
Fig. 8. (legend on next page)
84 Paradoxical roles cause by mutations in collagen X
Concomitantly, disease severity in these mice was
also increased based both on histological/histomor-
phometric analyses (Fig. 2), disruption to hypertro-
phic chondrocyte differentiation (Fig. 3) and
decreased rates of long bone growth (Table 1). In
contrast, Atf6β ablation in MCDS mice decreased
overall levels of growth plate ER stress (Fig. 9) and
decreased disease severity as judged by histologi-
cal/histomorphometric analyses (Fig. 7) and by the
improved hypertrophic differentiation apparent in the
Atf6β-ablated mice (Fig. 8).
Accordingly, both our in vivoand in vitro data provide
evidence that ATF6α most efficiently responds to and
ameliorates increases in ER stress in the absence of
ATF6β and that, in turn, a mix of ATF6α & β is the next
most effective combination with ATF6β alone being
least effective but why should this be? The two ATF6
isoforms need to dimerise to from an active transcrip-
tion factor and they can form homodimers or hetero-
dimers with each other or other factors such as XBP1s
[17,26,43]. As described previously, the transcriptional
activity of the ATF6α homodimer is far greater than
that of ATF6β [18,20,25–27]. Therefore, the ATF6α/β
heterodimer is likely to have an intermediate tran-
scriptional activity assuming both isoforms are
expressed/activated in equal quantities [26]. As such
ATF6α& β are not competing in an antagonistic sense
but the ratio of active α & β determines the level of
response froma “full-on” α-rich activity to amuch lower
level but still positive β-rich response. If ATF6βwere a
true “antagonist” the, latter response would be total
inhibition.
ATF6 and novel treatment strategies for MCDS
All three canonical signalling pathways of UPR
(IRE1, PERK, and ATF6) were shown to be
activated in response to the increased ER stress in
MCDS [6,7]. More recently, it was shown that the role
of IRE1/XBP1 branch of UPR in pathology of MCDS
is redundant and non-essential [9]. While the
physiological consequence of PERK ablation in
MCDS remained to be identified, our results pre-
sented above show that ATF6 signalling has a key
and indispensable role in MCDS pathology. Our
results reveal a chondroprotective role for ATF6α
and a much broader than anticipated role for ATF6β
in the pathology of MCDS.
Although targeting and enhancing the ATF6α-
dependent pathways and/or attenuating or blocking
the ATF6β-dependent pathways represent possible
novel avenues for future pursuit in terms of MCDS
therapy, translation into potential therapies for
MCDS would be challenging. Firstly, initial attempts
to selectively modulate the ATF6 arm of the UPR,
unlike PERK and IRE1, were unsuccessful largely
due to the lack of identifiable small molecule binding
sites on ATF6 [44–46]. Secondly, the great degree of
homology between ATF6α and -β, further adds to the
complexity of developing isoform selective modula-
tors. More importantly, management of ER stress in
vivo in the growth plate proved more complex than
initially anticipated, as the clear beneficial effect of
ATF6β ablation in hypertrophic chondrocytes was
nullified by the detrimental effect on the adjacent
proliferative chondrocytes. Therefore, a selective
blocking of ATF6β would need to be specifically
targeted to hypertrophic, whilst sparing proliferative
chondrocytes to avoid adverse effects on prolifera-
tion rate.
Recently, we showed that treatment with carba-
mazepine (CBZ) enhanced the degradation of
intercellular mutant collagen X proteins, alleviating
the ER stress and reducing the disease severity in
our MCDS mouse model [28]. Coupling CBZ
administration with, for instance, an ATF6α-activity
enhancing drug may prove an even more effective
therapy for such ER-stress driven diseases.
Materials and methods
Ethics statement
The animal experiments performed in this study
were approved by the University of Manchester
Animal Welfare and Ethical Review Body. Animals
were maintained, handled, and sacrificed in strict
accordance with United Kingdom Home Office
regulations.
Fig. 8. Effects of Atf6β ablation on chondrocytes differentiation. In situ hybridisation for (a) collagen X, (b) Bip,
(C) Osteopontin (black arrows), and (d) Mmp13 (black arrows) in tibial growth plate sections from three week old MCDS
mice with specified genotypes The presence of transcript is indicated by the dark blue staining. The hypertrophic zone is
indicated by the vertical red line and the vascular invasion front by the red dashes. The black boxed photomicrographs
represent an expanded view of the indicated areas within hypertrophic zones in the sections from specified genotypes.
(e) TRAP staining for osteoclasts (arrows) at the vascular invasion front (arrow head). (f) Snapshot of measurement of
height of the most terminal hypertrophy chondrocytes (HCs) for each specific genotype. HCs are indicated by the red
vertical lines and their corresponding measurements are highlighted in green. (arrow head = vif). (g) The number of
osteoclast per mm of vif. Mean ± SEM (5). *p b 0.05. (h) The average heights of the most terminal HCs. Mean ± SEM (5).
**p b 0.01 (i) TUNEL assay on tibial growth plate sections of three week old mice with specific genotypes. (Green stained
cells = apoptotic cells, blue-stained cells = DAPI, red dotted lines = vascular invasion front). Table (j) The number of apoptotic
HCsas apercentageof the total number of chondrocyteswithinHZ.Mean ± SEM (N ≥ 3). **p b 0.01. (k) qPCR forChopon ribs
growth plate extracts of three week old mice. Mean ± SEM (3). ****p b 0.0001 as determined by one way ANOVA.
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Transient transfection of HeLa cells with
collagen X constructs
The wild-type, and mutants expression constructs
encoding MCDS causing mutations in the full-length
collagen X (N671K, G618V, Y598D, and NC1del10)
were as described previously [30]. HeLa cells were
cultured in Dulbecco's Modified Eagle's Medium
(DMEM) (Sigma, D6429) supplemented with 10%
foetal bovine serum (FBS) (Life Technologies, 10,500-
064), penicillin (0.5 U/ml)/streptomycin (0.5 μg/ml)
(Sigma, P0781) and 1% non- essential amino acid
solution (Sigma, M7145) at 37 °C with 5% CO2. 24 h
prior to transfection, cells were passaged and seeded
at anappropriate density to achieve70%confluencyat
the time of transfection. Cells were transiently
Fig. 9. Effects of Atf6β ablation on the activities of PERK and IRE1 signalling pathways. (a) Total RNA from three pooled
ribs growth plate extracts of 21-day old mice were extracted and subjected to qPCR with XBP1 primers. Three
independent samples for each genotype are shown. Upper bands on the gel indicates Xbp1(U) with the size of 205 bp and
lower band is Xbp1s (size = 179 bp). (−RT = minus reverse transcriptase control). (b) A typical western blots of rib growth
plate extracts at three weeks of age for Atf4. Coomassie blue stained gel was used as loading control. (c) The average rate
of Xbp1 splicing from three independent samples for each genotype. (d) Quantification of Atf4 from three independent
experiments (**p b 0.01, ****p b 0.0001).
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transacted with 2 μg of collagen X expression
construct DNA using Lipofectamine 3000 (Life
Technologies, L3000) according to manufactures
instructions. Cells were incubated at 37 °C for 24 h.
Cell lysates were then harvested and further analysed
with qPCR or SDS-PAGE and western blotting.
siRNA-mediated gene silencing
A combination of two silencer® Select pre-designed
and validated small interfering RNAs (siRNAs) (life
technologies)wereused to knockdown the expression
of each gene of interest. For Atf6α: Atf6α Silencer®
Select pre-designed siRNA (Life Technologies,
s22688 & s22690) and for Atf6β Silencer® Select
pre-designed siRNA (Life Technologies, s223330 &
s3500). To achieve the best results HeLa cells were
first reverse transfected with either 20 nM of Atf6α or
10 nM of Atf6β siRNAs duplexes using Lipofectamine
RNAiMAX reagent (Life Technologies, 13,778) ac-
cording to manufactures protocol and incubated for
24 h at 37 °C. The following day media was removed
and cells were washed in PBS. siRNA-lipofectamine
RNAiMAX complexes were prepared as previous and
added drop-wise to the cells followed by overnight
incubation at 37 °C.After a total of 48 h, cell lysatewas
harvested and knockdown efficiency was assessed at
mRNA and protein levels with qPCR and SDS-PAGE
western blotting, respectively.
Co-transfection with Plasmid DNA and siRNAs
For co-transfection with plasmid DNA and siRNAs,
HeLa cells were first reverse transfected with optimal
concentrations of siRNA duplexes and RNAiMAX
lipofectamine as described above and incubated
for 24 h at 37 °C. The following day, media was
removed and cells were washed in PBS. Plasmid
DNA-lipofectamine 3000 complexes and siRNA-
lipofectamine 3000 complexes, were prepared as
described above and added drop-wise to the cells.
Cells were incubated at 37 °C for a further 24 h. After
total of 48 h, cell lysates were harvested and
analysed by qPCR and SDS-PAGE western blotting.
Harvesting protein samples from cells
Cell medium was discarded and cell layers were
washed in 1× PBS. PBS was then removed and 50 μl
2× SDS-PAGE sample buffer contained a PhosSTOP
phosphatase inhibitor cocktail (Roche, 04906845001)
and a complete mini-protease inhibitor (Roche,
11836170001) and 10 μM MG132 proteasomal inhib-
itor (Sigma, M7449) was added to the each well of a
6-well plate. Cells were scarped using a cell scarper
and placed into a 1.5 ml tube. Samples were heated
for 10 min at 99 °Cand then centrifuged at 13,000 rpm
for 10 min at 4 °C. The lysate supernatant was
transferred into a fresh 1.5 ml tube and the concen-
tration of protein in the lysate was calculated using
BCA assay (Thermo Scientific # 23227) with a bovine
serum albumin standard curve according to manufac-
turer's protocol.
SDS-PAGE and western blotting
40 μg of protein per sample for Atf6α protein
detection and 20 μg of protein for all other proteins
were loaded into the precaste NuPAGE® Novex®
4–12% Bis-Tr is Gels (L i fe technologies,
NP0322BOX). The gel was electroblotted onto a
nitrocellulose membrane, which was blocked 1 h at
room temperature with 5% skimmed milk powder in
PBS containing 0.1% tween-20 and 2% (v/v) serum
derived from the same species in which the
secondary antibody was produced. The membranes
were incubated in 1/500 dilution of Grp78/BiP (Santa
Cruz, SC-1051), CRELD2 (Santa Cruz, sc-86110),
and ATF6α (37–1) (Cosmo Bio Co, 73-505EX)
primary antibodies and 1/1000 dilution of ATF6α
(1–7) (BAM-73-500-EX), anti-ATF4 (Cell Signalling,
11815), Mouse IgG1 anti-His clone # (AD1.1.10) (R
& D, MAB050), and GAPDH (L−20) (Santa Cruz, sc-
31,915) primary antibodies in blocking solution
overnight at 4 °C. Polyclonal rabbit anti-ATF6β
antibody was produced as described previously
[11]. It was diluted 1/333 in blocking solution
overnight at 4 °C.
Membranes were then incubated with an appro-
priate HRP conjugated secondary antibody. An ECL
detection kit (Life Technologies) and ECL hyperfilm
(GE Healthcare) was used to develop the blots
according to manufacturer's protocol.
The blots were quantified by densitometry analysis
using ImageJ software on images from scanned
films within the linear range of exposure. The
intensity of each band was calculated relative to a
loading control and standardised against a control
protein sample on each blot. The result were
analysed by ANOVA for statistical significance
using GraphPad Prism 6.0 software.
RT-qPCR analysis
Purification of RNA from cell lysate and homo-
genised ribs growth plate extracts in TRIzol reagent
(Life Technologies) was performed using phenol and
chloroform methodology. cDNA was synthesised
from 1 μg of purified and DNase treated (Ambion,
AM1906) RNA samples using the Taqman Reverse
Transcription Reagent Kit (Applied Biosystems UK,
N8080234) according to manufacturer's protocol.
The following primers were used for real time qPCR:
ATF6α forward 5′-CACAGCTCCCTAATCACGT
GG-3′ and reverse 5′-ACTGGGCTA TTCGCTGAA
GG, ATF6β forward 5′-CAGCCATCAGCCACAA-
CAAG-3′ and reverse 5′-GGCATCACCAGGGA-
CATCTT-3′, CRELD2 forward 5′-GGGCTGGTGG
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ACAAGTTTAAC-3′ and reverse 5′-CGAATCTCGCT
GGACTCGTA-3′, ARMET forward 5′-TCACATTCT-
CACCAGCCACT-3′ and reverse 5′-TCACATTCTCAC
CAGCCACT-3′, BiP forward 5′-GCTAATGCTTATGG
CCTGGA-3′ and reverse 5′-CGCTGGTCAAAGTCTT
CTCC-3′, CHOP human forward 5′-GCGCATGAAG-
GAGAAAGAAC-3′ and reverse 5′-TCTGGGAAAGG
TGGGTAGTG-3′, CHOP mouse forward 5′-CCACCA-
CACCTGAAAGCAGAA-3′ and reverse 5′-AGGTGCC
CCCAATTTCATCT, splicedXBP1 forward5′-GAAGC-
CAAGGGGAATGAAGT-3′ and reverse 5′-CCA-
GAATGCCCAACAGGATA-3′,and β-actin forward
5′-CCACCATGTACCCAGGCATT-3′ and reverse 5′-
CACATCTGCTGGAAGGTGGA-3.
Each reaction was performed in duplicate using a
StepOnePlusTM Real-Time PCR system (Life Tech-
nologies, 4376600). A no-template control was used
along with other samples to check for contamination.
The data generated from the real time PCR was
analysed by ANOVA for statistical significance using
GraphPad Prism 6.0 software.
Quantification of the mRNA level of the spliced form
of XBP1 was performed as previously described [47].
Briefly, the synthesised single- stranded cDNAs were
subjected to an initial 4 cycles of PCR tomake double-
stranded cDNAs as follow: 95 °C for 3 min, 4 cycles of
95 °C for 40 s, 60 °C for 45 s and 72 °C for 40 s, and
then 10 min at 72 °C. In order to eliminate the
unspliced form of XBP1 (XBP1U), which contains a
PstI restriction site within its sequence [47], the
double-stranded cDNA mix was digested with 1.25 μl
of PstI restriction enzyme overnight at 37 °C. Subse-
quently the samples containing only spliced form of
XBP1 (XBP1s) were subjected to a quantitative real
time PCR as describe above.
Generation of Atf6α− /−/ MCDS and Atf6β− /−/
MCDS mice
Col10a1 p.Asn 617Lysmice (ColX p.N617Km/m) [7]
were crossed with mice that were knockout either for
Atf6α or Atf6β [2] to generate the compound mutants,
Atfα− /−/Col10a1 p.N617Km/m and Atf6β− /−/Col10a1
p.N617Km/m (ATF6α− / −/MCDS and ATF6β− / −/
MCDS respectively). These mice were viable, fertile,
bred normally and were handled in accordance with
the Home Office Scientific Procedure Act (1986)
guidelines. Genotyping was performed as previously
described [7,18].
Skeletal analysis
Mice at 3, 6, and 9 weeks of age were radio-
graphed using a Flaxitron X-ray specimen radiogra-
phy system (Flaxitron MX-20) and X-ray hyperfilm
(GE Healthcare, GZ28906850). The lengths of femur
and tibia bones and inner canthal distances (ICD)
were measured from scanned radiographic images.
All measurements were analysed by ANOVA for
statistical significance using GraphPad Prism 6.0
software.
Histology
The hind limbs were dissected, fixed and processed
as previously described [28] prior to histological
staining, immunohistochemistry or in situ hybridisation.
H & E staining
H + E staining was performed as described previ-
ously [7] and all images taken using a Carl Zeiss
Axiovision microscope fitted with an Axiocam colour
CCD camera and associated Axiovision software.
Growth plate zonewidths weremeasured on images
of knownmagnificationasdescribedpreviously [7]. The
height of PZ was defined from the point where round
resting chondrocytes align into columns and become
disc shaped to the point where HZ starts. The start of
HZ was defined as proliferative chondrocytes stop
proliferation, roundupandbecome larger. Thevascular
invasion front was defined as the end point of HZ. For
each animal, five slides at least 75 μm apart were
measured and averaged. Measurements were ana-
lysed for statistical significance by ANOVA using
GraphPad Prism 6.0 software. To measure heights of
the most terminal hypertrophic chondrocytes (HCs)
which is the height parallel to the direction of growth,
four H&E stained slides per animal, at least 75 μm
apart, were scanned using a digital slide scanner
(Pannoramic 250 Flash, 3DHISTECH) and then
analysed by an associated panoramic viewer software.
For each tissue section, heights of one hundred
hypertrophic chondrocytes located at the vicinity of
vascular invasion front (the last three rows) were
measured and averaged. The average height of the
most terminal HCs for each animal was defined as an
overall average between all related slides. All data were
analysed by one-wayANOVA for statistical significance.
Immunohistochemistry (IHC)
Immunohistochemistry for collagen X, BiP, and
CRELD2 was performed on acetic acid/ethanol fixed
tibial growth plate sections using the following
primary antibodies; collagen X (polyclonal rabbit
anti-collagen X against recombinant mouse NC1
domain), anti-Grp 78 goat polyclonal (Santa Cruz,
SC-1051), and CRELD2 (R & D system, H3884) as
previously described [7,48,49].
Tartrate-resistant acidphosphatase (TRAP)staining
Osteoclasts at the vascular invasion front were
stained using a TRAP staining kit (Sigma- Aldrich
387A) according to manufacturer's instructions. The
number of positively stained cells (red/brown) were
quantified per mm of vascular invasion front as
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described previously [28] in 3 sections per animal
spaced 50 μm apart in 3 animals per genotype and
analysed by one-way ANOVA for statistical
significance.
Bromodeoxyuridine (BrdU) labelling
BrdU labelling and analysis was performed as
previously described [7]. At least three animals per
genotype were included and analysed by one-way
ANOVA for statistical significance.
Terminal transferase dUTP Nick End Labelling
(TUNEL) assay
TUNEL assay was performed on tibial growth plate
sections of three-week old mice using a fluorometric
TUNEL kit (Promega, G3250) according to manu-
facturer's protocol as describe previously [49].The
slides were mounted with Vectashield with DAPI
(Vector Laboratories, H1200) and imaged using the
CoolSNAP ES Olympus BX51 camera and associ-
ated Metaview software. In order to obtain a reliable
estimate of number of apoptotic hypertrophic cells in
the growth plate, the green fluorescent apoptotic
cells within the HZ were counted in three slides, at
least 50 μm apart, per mouse and five animals for
each genotype. The total number of hypertrophic
chondrocytes within the HZ was defined by the
number of DAPI-stained nuclei (as determined using
ImageJ software). The apoptosis rate was defined
as a percentage of the total number of hypertrophic
cells within HZ. All data were analysed by one-way
ANOVA for statistical significance.
In situ hybridisation (ISH)
DIG-labelled colourimetric ISH was performed as
previously described [7]. The resulting cDNA probes
were cloned into pT7T3, linearised and transcribed
using the appropriate restriction enzyme and RNA
polymerase.
Ribs growth plate extraction for use in western
blotting
Protein extracts from ribs growth plate for western
blotting were obtained as described previously
[7,49]. Dissected growth plates from at least 3 mice
were pooled together and placed either in 100 μl 2×
SDS-PAGE sample buffer for western blotting or in
500 μl of TRIzol (Life Technologies, 15596018) for
RNA extraction. Dissected growth plates were then
homogenised using a micro-dismembranator. For
western blotting, the homogenised rib growth plate
extracts were boiled in SDS loading buffer containing β
mercaptoethanol and centrifuged. The supernatant
was collected and total protein concentration was
assayed using the Pierce bicinchoninic acid (BCA)
protein assay (ThermoScientific # 23227)with a bovine
serum albumin standard curve according to manufac-
turer's protocol. Protein extracts wee then analysed by
SDS-PAGE and western blotting.
PCR analysis to detect Xbp1 splicing in mouse
rib extracts
Detection of Xbp1 splicing on the rib growth plates
from 3 week old mice were carried out as described
previously [49]. 1 μg purified rib total RNAwas reverse
transcribed to cDNA using the Taqman Reverse
Transcription Reagent Kit (Life Technologies) accord-
ing to manufacturer's protocol and subjected to PCR
with primers flanking the Xbp1 ER stress-responsive
splice site F: 5′-GAACCAGGAGTTAAGAACACG-3′
and R: 5′-AGGCAACAGTGTCAGAGTCC-3′. PCR
products, Xbp1U with the size of 205 bp and Xbp1s
with the size of 179 bp, were then separated on 3%
agarose gel. The level of Xbp1 splicing was then
calculated as a percentage of the total Xbp1 (Xbp1s +
Xbp1 U) using Image J software.
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.matbio.2018.03.004.
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